The Research and Development team at NewLink Genetics is responsible for advancing the company's immunotherapeutic product pipeline. This includes the discovery and development of new biologic and small-molecule therapies, ensuring clinical efficacy, overseeing intellectual property, and optimizing process development for clinical trials and commercialization.